Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Innospec (IOSP) EBT Margin (2016 - 2025)

Historic EBT Margin for Innospec (IOSP) over the last 17 years, with Q3 2025 value amounting to 2.6%.

  • Innospec's EBT Margin fell 75000.0% to 2.6% in Q3 2025 from the same period last year, while for Sep 2025 it was 1.91%, marking a year-over-year decrease of 81800.0%. This contributed to the annual value of 4.89% for FY2024, which is 40600.0% down from last year.
  • Innospec's EBT Margin amounted to 2.6% in Q3 2025, which was down 75000.0% from 7.25% recorded in Q2 2025.
  • Innospec's EBT Margin's 5-year high stood at 11.31% during Q2 2021, with a 5-year trough of 11.48% in Q4 2024.
  • Over the past 5 years, Innospec's median EBT Margin value was 9.07% (recorded in 2021), while the average stood at 7.87%.
  • Its EBT Margin has fluctuated over the past 5 years, first surged by 332800bps in 2021, then plummeted by -206400bps in 2024.
  • Over the past 5 years, Innospec's EBT Margin (Quarter) stood at 7.91% in 2021, then increased by 12bps to 8.85% in 2022, then grew by 3bps to 9.16% in 2023, then tumbled by -225bps to 11.48% in 2024, then skyrocketed by 123bps to 2.6% in 2025.
  • Its last three reported values are 2.6% in Q3 2025, 7.25% for Q2 2025, and 10.07% during Q1 2025.